Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

por Shettle, Lee, McLaurin, Eugene, Martel, Joseph, Seaman, John W, Weissgerber, Georges
Publicado 2022

Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis

por Schmidt-Erfurth, Ursula, Mulyukov, Zufar, Gerendas, Bianca S., Reiter, Gregor S., Lorand, Daniel, Weissgerber, Georges, Bogunović, Hrvoje
Publicado 2022

Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study

por Pasquali, Theodore A., Toyos, Melissa M., Abrams, David B., Scales, David K., Seaman, John W., Weissgerber, Georges
Publicado 2022

Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

por Ogura, Yuichiro, Jaffe, Glenn J, Cheung, Chui Ming Gemmy, Kokame, Gregg T, Iida, Tomohiro, Takahashi, Kanji, Lee, Won Ki, Chang, Andrew A, Monés, Jordi, D’Souza, Divya, Weissgerber, Georges, Gedif, Kinfemichael, Koh, Adrian
Publicado 2022